BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lee JE, Kim MY. Cancer epigenetics: Past, present and future. Semin Cancer Biol 2021:S1044-579X(21)00075-4. [PMID: 33798724 DOI: 10.1016/j.semcancer.2021.03.025] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Armeev GA, Gribkova AK, Shaytan AK. Nucleosomes and their complexes in the cryoEM era: Trends and limitations. Front Mol Biosci 2022;9. [DOI: 10.3389/fmolb.2022.1070489] [Reference Citation Analysis]
2 Berlanga-Acosta J, Fernandez-Mayola M, Mendoza-Mari Y, Garcia-Ojalvo A, Martinez-Jimenez I, Rodriguez-Rodriguez N, Garcia Del Barco Herrera D, Guillén-Nieto G. Cell-Free Filtrates (CFF) as Vectors of a Transmissible Pathologic Tissue Memory Code: A Hypothetical and Narrative Review. Int J Mol Sci 2022;23:11575. [PMID: 36232877 DOI: 10.3390/ijms231911575] [Reference Citation Analysis]
3 Liu P, Luo J, Xu J, Tan N, Li C, Yang X. Establishing a prognostic model of chromatin modulators and identifying potential drug candidates in renal clear cell patients Introduction.. [DOI: 10.21203/rs.3.rs-2090858/v1] [Reference Citation Analysis]
4 Xu N, Liu J, Li X. Lupus nephritis: The regulatory interplay between epigenetic and MicroRNAs. Front Physiol 2022;13:925416. [DOI: 10.3389/fphys.2022.925416] [Reference Citation Analysis]
5 Yang Y, Zhang M, Wang Y. The roles of histone modifications in tumorigenesis and associated inhibitors in cancer therapy. Journal of the National Cancer Center 2022. [DOI: 10.1016/j.jncc.2022.09.002] [Reference Citation Analysis]
6 Du L, Lu Y, Wang J. Editorial: The role of interplay between metabolism and chromosomes in tumorigenesis. Front Cell Dev Biol 2022;10:981075. [PMID: 36036005 DOI: 10.3389/fcell.2022.981075] [Reference Citation Analysis]
7 Li Y, Liu F, Liu W, Zhang Y, Tian X, Fu X, Xu Y, Song J, Zhang S. A novel aromatic amide derivative SY-65 co-targeted tubulin and histone deacetylase 1 with potent anticancer activity in vitro and in vivo. Biochemical Pharmacology 2022;201:115070. [DOI: 10.1016/j.bcp.2022.115070] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Rincón-riveros A, Rodríguez JA, Villegas VE, López-kleine L. Identification of Two Exosomal miRNAs in Circulating Blood of Cancer Patients by Using Integrative Transcriptome and Network Analysis. ncRNA 2022;8:33. [DOI: 10.3390/ncrna8030033] [Reference Citation Analysis]
9 Paweł K, Maria Małgorzata S. CpG Island Methylator Phenotype-A Hope for the Future or a Road to Nowhere? Int J Mol Sci 2022;23:830. [PMID: 35055016 DOI: 10.3390/ijms23020830] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
10 Ahmad A. Special Issue: Epigenetic regulation of cancer progression: Promises and progress. Semin Cancer Biol 2021:S1044-579X(21)00298-4. [PMID: 34921992 DOI: 10.1016/j.semcancer.2021.12.005] [Reference Citation Analysis]
11 Gao L, Wu ZX, Assaraf YG, Chen ZS, Wang L. Overcoming anti-cancer drug resistance via restoration of tumor suppressor gene function. Drug Resist Updat 2021;57:100770. [PMID: 34175687 DOI: 10.1016/j.drup.2021.100770] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 21.0] [Reference Citation Analysis]